A U.S. federal jury has ruled that Apple owes medical technology company Masimo $634 million for patent infringement related to the blood oxygen-sensing technology in the Apple Watch, reports Reuters.

Early last year, Apple made the bold, court-mandated decision to remove the blood-oxygen feature from the Apple Watch Series 9 and Ultra 2 in the U.S. over a patent dispute with medical technology ...

In early 2024, Apple removed a blood oxygen monitoring feature from its then-current Apple Watch Series 9 and Ultra 2 watches, following a ruling that the feature violated light-based pulse oximetry ...

Katie is a UK-based news reporter and features writer. Officially, she is CNET's European correspondent, covering tech policy and Big Tech in the EU and UK. Unofficially, she serves as CNET's Taylor ...